WILLIAM KUJAWSKI: Open Payments
NPI 1851392716 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 46 payments from 20 companies in 2025. Trend: 2023 $802 · 2024 $1,178 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $158 |
| Axsome Therapeutics, Inc. | 6 | $131 |
| ABBVIE INC. | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 5 | $78 |
| Inspire Medical Systems, Inc. | 2 | $75 |
| Lilly USA, LLC | 4 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Verity Pharmaceuticals Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: Auvelity, VOQUEZNA, INSPIRE, UBRELVY, Rybelsus, MOUNJARO, Wegovy, Ozempic.
Industry payments across TX — which companies pay providers there.
